Literature DB >> 30697577

DNA methylation in development and disease: an overview for prostate researchers.

Diya B Joseph1, Douglas W Strand2, Chad M Vezina1.   

Abstract

Epigenetic mechanisms including DNA methylation are critical regulators of organismal development and tissue homeostasis. DNA methylation is the transfer of methyl groups to cytosines, which adds an additional layer of complexity to the genome. DNA methylation marks are recognized by the cellular machinery to regulate transcription. Disruption of DNA methylation with aging or exposure to environmental toxins can change susceptibility to disease or trigger processes that lead to disease. In this review, we provide an overview of the DNA methylation machinery. More specifically, we describe DNA methylation in the context of prostate development, prostate cancer, and benign prostatic hyperplasia (BPH) as well as the impact of dietary and environmental factors on DNA methylation in the prostate.

Entities:  

Keywords:  BPH; DNMT1; Epigenetics; aging; demethylase; development; prostate cancer

Year:  2018        PMID: 30697577      PMCID: PMC6334199     

Source DB:  PubMed          Journal:  Am J Clin Exp Urol        ISSN: 2330-1910


  186 in total

1.  DNA hypomethylation perturbs the function and survival of CNS neurons in postnatal animals.

Authors:  G Fan; C Beard; R Z Chen; G Csankovszki; Y Sun; M Siniaia; D Biniszkiewicz; B Bates; P P Lee; R Kuhn; A Trumpp; C Poon; C B Wilson; R Jaenisch
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

2.  CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus.

Authors:  A T Hark; C J Schoenherr; D J Katz; R S Ingram; J M Levorse; S M Tilghman
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

3.  Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals.

Authors:  C Gupta
Journal:  Proc Soc Exp Biol Med       Date:  2000-06

4.  Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 gene.

Authors:  C Y Howell; T H Bestor; F Ding; K E Latham; C Mertineit; J M Trasler; J R Chaillet
Journal:  Cell       Date:  2001-03-23       Impact factor: 41.582

5.  Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation.

Authors:  L Jackson-Grusby; C Beard; R Possemato; M Tudor; D Fambrough; G Csankovszki; J Dausman; P Lee; C Wilson; E Lander; R Jaenisch
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

6.  DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.

Authors:  M Okano; D W Bell; D A Haber; E Li
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

7.  Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression.

Authors:  L C Li; R Chui; K Nakajima; B R Oh; H C Au; R Dahiya
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

8.  DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci.

Authors:  M R Rountree; K E Bachman; S B Baylin
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

9.  The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors.

Authors:  K D Robertson; E Uzvolgyi; G Liang; C Talmadge; J Sumegi; F A Gonzales; P A Jones
Journal:  Nucleic Acids Res       Date:  1999-06-01       Impact factor: 16.971

10.  MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex.

Authors:  H H Ng; Y Zhang; B Hendrich; C A Johnson; B M Turner; H Erdjument-Bromage; P Tempst; D Reinberg; A Bird
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

View more
  5 in total

1.  Combined screening analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.

Authors:  Jisen Cao; Ruiqiang Zhang; Ye Zhang; Yijun Wang
Journal:  J Gastrointest Oncol       Date:  2022-02

2.  Markers of ovarian reserve are associated with reproductive age acceleration in granulosa cells from IVF patients.

Authors:  A K Knight; H S Hipp; S Abhari; S A Gerkowicz; Q S Katler; L J McKenzie; W Shang; A K Smith; J B Spencer
Journal:  Hum Reprod       Date:  2022-09-30       Impact factor: 6.353

Review 3.  PRMT5: a putative oncogene and therapeutic target in prostate cancer.

Authors:  Elena Beketova; Jake L Owens; Andrew M Asberry; Chang-Deng Hu
Journal:  Cancer Gene Ther       Date:  2021-04-14       Impact factor: 5.854

4.  Fasciola gigantica excretory-secretory products (FgESPs) modulate the differentiation and immune functions of buffalo dendritic cells through a mechanism involving DNMT1 and TET1.

Authors:  Xuefang Mei; Wei Shi; Wenping Zhao; Honglin Luo; Yaoyao Zhang; Yurui Wang; Zhaoan Sheng; Dongying Wang; Xing-Quan Zhu; Weiyi Huang
Journal:  Parasit Vectors       Date:  2020-07-17       Impact factor: 3.876

Review 5.  Methyl Donor Micronutrients that Modify DNA Methylation and Cancer Outcome.

Authors:  Abeer M Mahmoud; Mohamed M Ali
Journal:  Nutrients       Date:  2019-03-13       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.